Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
CN Stock MarketDetailed Quotes
688580 Nanjing Vishee Medical Technology Co., Ltd
- 43.37
- +5.98+15.99%
Post Market Apr 25 15:00 CST
4.15BMarket Cap36.63P/E (TTM)
43.67High39.49Low58.27KlotVolume39.49Open37.39Pre Close241.98MTurnover6.08%Turnover Ratio40.72P/E (Static)95.77MShares48.3752wk High2.50P/B4.15BFloat Cap20.2652wk Low44.87Limit Up95.77MShs Float166.58Historical High29.91Limit Down11.18%Amplitude20.26Historical Low1.08Dividend TTM41.53Avg Price21.23KlotAsk2.49%Div YieldTTM100Lot Size31.37KlotBid
Nanjing Vishee Medical Technology Co., Ltd Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 9.40%95.91M | -13.45%400.06M | -12.06%291.76M | -12.84%191.58M | -8.24%87.67M | 43.72%462.22M | 53.19%331.77M | 63.87%219.8M | 76.57%95.54M | -25.21%321.62M |
| Operating revenue | 9.40%95.91M | -13.45%400.06M | -12.06%291.76M | -12.84%191.58M | -8.24%87.67M | 43.72%462.22M | 53.19%331.77M | 63.87%219.8M | 76.57%95.54M | -25.21%321.62M |
| Total operating cost | -8.26%66.4M | -6.40%324.85M | -5.80%231.83M | -1.88%154.66M | 1.60%72.38M | 40.48%347.04M | 41.75%246.11M | 40.88%157.63M | 46.10%71.24M | -10.79%247.04M |
| Operating cost | 5.55%31.98M | -7.33%138.23M | -11.01%84.37M | -10.50%56.3M | 10.87%30.3M | 68.51%149.16M | 64.45%94.8M | 78.78%62.9M | 98.56%27.33M | -18.38%88.52M |
| Operating tax surcharges | 10.43%1.41M | -3.39%5.53M | -1.09%3.97M | -5.84%2.64M | -0.62%1.28M | 43.77%5.73M | 53.65%4.02M | 75.82%2.8M | 115.12%1.29M | -26.74%3.98M |
| Operating expense | -17.72%14.86M | -10.11%94.37M | -10.80%78.09M | -11.76%50.3M | -30.15%18.06M | 14.69%104.99M | 41.87%87.55M | 50.85%57M | 71.77%25.85M | 17.21%91.54M |
| Administration expense | -25.09%9.53M | -6.20%44.55M | 1.64%33.64M | 24.42%24.14M | 31.75%12.72M | 24.42%47.49M | 14.67%33.09M | 2.36%19.4M | -2.58%9.66M | 0.50%38.17M |
| Financial expense | 80.62%-1.05M | 53.03%-8.45M | 45.76%-8.17M | 26.81%-7.45M | -16.90%-5.41M | 4.88%-17.98M | -8.91%-15.05M | -31.74%-10.18M | -32.47%-4.63M | -14.06%-18.9M |
| -Interest expense (Financial expense) | 9.13%351.26K | -0.74%1.31M | -3.83%965.57K | 1.78%643.72K | -1.59%321.86K | 294.72%1.32M | 888.64%1M | 774.78%632.48K | 804.68%327.05K | 80.86%334.05K |
| -Interest Income (Financial expense) | 75.43%-1.4M | 49.40%-9.77M | 43.08%-9.15M | 25.12%-8.11M | -15.75%-5.71M | -0.18%-19.32M | -15.20%-16.07M | -38.62%-10.84M | -39.45%-4.93M | -14.77%-19.28M |
| Research and development | -37.36%9.66M | -12.21%50.61M | -4.26%39.93M | 11.80%28.73M | 31.42%15.43M | 31.83%57.65M | 13.91%41.71M | -1.51%25.7M | -9.18%11.74M | -31.15%43.73M |
| Credit Impairment Loss | -645.77%-84.19K | 41.68%-1.28M | 49.37%-133.33K | -146.10%-139.75K | -117.72%-11.29K | -222.02%-2.19M | -182,901.57%-263.36K | -158.16%-56.78K | -79.99%63.7K | 23.72%-679.57K |
| Asset Impairment Loss | ---- | ---29.23K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | ||||||||||
| Fair value change income | ---- | 350.97%2.42M | ---- | ---- | ---- | ---964.05K | ---- | ---- | ---- | ---- |
| Invest income | 175.78%3.13M | 7.16%11.34M | 15.34%8.24M | -0.68%5M | -64.96%1.13M | -33.92%10.58M | -46.16%7.14M | -50.94%5.04M | -39.20%3.24M | -22.11%16.01M |
| Asset deal income | ---864.63 | 285.01%3.91K | -88.60%434.96 | -88.60%434.96 | ---- | ---2.11K | --3.81K | --3.81K | --3.81K | ---- |
| Other revenue | -27.72%4.49M | -7.73%23.84M | -14.01%16.33M | 14.07%11.07M | 33.57%6.21M | 77.68%25.83M | 87.79%18.99M | 37.26%9.71M | -5.89%4.65M | -33.57%14.54M |
| Operating profit | 63.73%37.04M | -24.88%111.5M | -24.36%84.36M | -31.23%52.86M | -29.86%22.62M | 42.11%148.44M | 68.13%111.53M | 93.72%76.86M | 102.49%32.26M | -46.34%104.46M |
| Add:Non operating Income | -95.53%4.56K | 14.56%1.85M | -79.33%143.81K | -82.41%118.01K | -84.06%102.05K | 12.86%1.61M | -36.43%695.78K | -37.92%671.06K | -70.16%640.13K | -48.08%1.43M |
| Less:Non operating expense | ---- | 67.48%70.83K | -36.96%28.53K | -36.73%28.53K | ---- | -4.69%42.29K | 1,324.51%45.25K | 1,319.34%45.09K | 897.30%31.68K | -9.88%44.37K |
| Total profit | 63.02%37.05M | -24.49%113.28M | -24.70%84.48M | -31.67%52.95M | -30.85%22.73M | 41.73%150.01M | 66.37%112.19M | 90.13%77.49M | 81.86%32.86M | -46.38%105.84M |
| Less:Income tax cost | 293.56%3.83M | -17.77%11.31M | -39.94%6.31M | -51.99%3.33M | -65.05%972.31K | 14.47%13.75M | 99.62%10.5M | 177.49%6.93M | 162.12%2.78M | -39.46%12.01M |
| Net profit | 52.71%33.22M | -25.16%101.97M | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.15%93.83M |
| Net profit from continuing operation | 52.71%33.22M | -25.16%101.97M | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.15%93.83M |
| Net profit of parent company owners | 52.71%33.22M | -25.16%101.97M | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.23%93.83M |
| Earning per share | ||||||||||
| Basic earning per share | 52.08%0.3472 | -25.07%1.0685 | -22.88%0.8221 | -29.48%0.5216 | -48.18%0.2283 | 3.79%1.426 | 17.12%1.066 | 32.05%0.7396 | 77.02%0.4406 | -47.19%1.3739 |
| Diluted earning per share | 52.35%0.3472 | -25.09%1.0665 | -22.97%0.8205 | -29.65%0.5202 | -48.28%0.2279 | 3.69%1.4237 | 17.29%1.0652 | 32.27%0.7394 | 77.59%0.4406 | -47.07%1.3731 |
| Other composite income | ||||||||||
| Total composite income | 52.71%33.22M | -25.16%101.97M | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.15%93.83M |
| Total composite income of parent company owners | 52.71%33.22M | -25.16%101.97M | -23.13%78.17M | -29.67%49.62M | -27.69%21.75M | 45.22%136.26M | 63.56%101.68M | 84.43%70.56M | 76.85%30.08M | -47.23%93.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs